Chemo-Sensitization of CD133+ Cancer Stem Cell Enhances the Effect of Mesenchymal Stem Cell Expressing TRAIL in Non-Small Cell Lung Cancer Cell Lines
Pre-clinical studies have demonstrated the efficacy of mesenchymal stem cells (MSCs) expressing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) or MSC-TRAIL against several tumors. However, due to the existence of cancer stem cells (CSCs), some tumors, including non-small cell...
Guardado en:
Autores principales: | Kamal Shaik Fakiruddin, Moon Nian Lim, Norshariza Nordin, Rozita Rosli, Syahril Abdullah |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dd01ea0118ab45629205f86b0832e7ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
por: Taiga Seki, et al.
Publicado: (2021) -
Stem cell technology in breast cancer: current status and potential applications
por: Chiotaki R, et al.
Publicado: (2016) -
Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors
por: Zhang M, et al.
Publicado: (2020) -
Isolation Set-up and Characterization of cancer stem cells from HT29 colon cancer cell line
por: Pooneh Mokarram, et al.
Publicado: (2021) -
Stem cells and development
Publicado: (2004)